M. Velasco

发表

Cetuximab Combined With Induction Oxaliplatin and Capecitabine, Followed by Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: SWOG 0713

H. Lenz, A. Hezel, H. Hochster, 2017, Clinical colorectal cancer.

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117.

C. Bloomfield, F. Appelbaum, R. Stone, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive‐stage small cell lung cancer: A trial of the ECOG‐ACRIN Cancer Research Group (E1508)

C. Rudin, Helen X. Chen, M. Monga, 2016, Cancer.

Phase II Trial of Cediranib in Combination With Cisplatin and Pemetrexed in Chemotherapy-Naïve Patients With Unresectable Malignant Pleural Mesothelioma (SWOG S0905).

I. Wistuba, J. Heymach, K. Kelly, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Additional Analyses of a Randomized Phase II Study of Azacitidine Combined with Lenalidomide or with Vorinostat Vs. Azacitidine Monotherapy in Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML): North American Intergroup Study SWOG S1117

C. Bloomfield, F. Appelbaum, R. Stone, 2014 .

Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial

John D. Roberts, J. Foster, C. Shapiro, 2017, JAMA.

Effectof Longer-Interval vsStandardDosingofZoledronicAcid on Skeletal Events in PatientsWith BoneMetastases A Randomized Clinical Trial

John D. Roberts, J. Foster, C. Shapiro, 2016 .

Marginal zone variant of mantle cell lymphoma: CD5‐negative cyclin D1‐positive variant posing a diagnostic dilemma

M. Velasco, M. Elghetany, N. Golardi, 2009, Pathology international.

Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma

V. Sondak, T. Karrison, D. Olson, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013

C. Moinpour, M. Lacouture, A. Barzi, 2020, Journal of Patient-Reported Outcomes.

Cetuximab for the treatment of advanced bronchioloalveolar carcinoma (BAC): an Eastern Cooperative Oncology Group phase II study (ECOG 1504).

S. Ramalingam, J. Kolesar, J. Schiller, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Carboplatin, Paclitaxel, Cetuximab, and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Nonsquamous Non–Small-Cell Lung Cancer: SWOG S0536

Edward S. Kim, R. Herbst, F. Hirsch, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Personalized Management of Chemotherapy‐Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance)

E. Winer, M. Ratain, C. Hudis, 2019, Journal of clinical pharmacology.